Save-the-Date, October
16-17, 2006
Drug Abuse Conference Scheduled in Seattle
NIDA to Host
“Blending Addiction Science & Practice: Bridges to the
Future”
|
| What: |
A two-day conference that will bring
together clinicians and researchers to examine cutting-edge scientific
findings about drug abuse and addiction and their application to clinical
practice. |
| Why: |
A gap exists in the drug abuse treatment
field between clinical practice and scientific research. This conference
is part of an ongoing effort to bring the newest treatments to
community practice. |
| Hosts: |
National Institute on Drug Abuse,
National Institutes of Health Washington and Oregon/Hawaii Nodes
of the
National Drug Abuse Treatment Clinical Trials Network. |
| When: |
Monday and Tuesday, October 16 & 17, 2006 |
| Where: |
Washington State Convention and Trade
Center 800 Convention Place Seattle, Washington |
| Who Should Attend: |
Drug
treatment counselors, social workers, healthcare providers, criminal
justice staff, marriage and family counselors, public
health workers, physicians, researchers interested in drug abuse
and addiction issues, and the media are encouraged to attend. |
Info: Blending Conference Overview
Plenary sessions will be presented by Nora D. Volkow, M.D., Director,
National Institute on Drug Abuse (NIDA) and other experts in the
field of drug abuse and addiction. The conference will include
sessions on:
- Sexual Risk Reduction Interventions for Substance Abuse Treatment
Programs
- Promoting Awareness of Motivational Incentives
- What is Gender-Specific Treatment for Women?
- Evidence-Based Treatment in Correctional Settings
- Integrated Treatment for Trauma and Addiction-Seeking Safety
- Managing Pain and Addiction in Diverse Treatment Settings
|
More details about the conference are available on NIDA’s website
at http://www.drugabuse.gov.
Dr. Nora D. Volkow
Director, National Institute on Drug Abuse, National Institutes of
Health
Dr. Nora D. Volkow was appointed Director of NIDA in May 2003.
She is recognized as one of the world’s leading experts on drug
addiction and brain imaging. Her work has been pivotal in demonstrating
that drug addiction is a disease of the brain. She pioneered the
use of brain imaging to investigate the toxic effects of drugs
and the effects of drugs responsible for their addictive properties
in the human brain. In addition, she has led important research
in the areas of obesity, schizophrenia, aging, and ADHD. Dr. Volkow
has published more than 330 peer-reviewed articles, more than 50
book chapters and non-peer-reviewed manuscripts, and also edited
three books on the use of neuroimaging in studying mental and addictive
disorders. A recipient of multiple awards, she was elected to membership
in the Institute of Medicine, National Academy of Sciences, and
was named “Innovator of the Year” in 2000 by U.S. News and
World Report.
For more information or to arrange an interview with Dr. Volkow,
please contact the NIDA Press Office at 301-443-6245. Dr. Volkow
is bilingual and media interviews can be conducted in either English
or Spanish.
The National Institute on Drug Abuse is a component of the
National Institutes of Health, U.S. Department of Health and
Human Services. NIDA supports most of the world's research on
the health aspects of drug abuse and addiction. The Institute
carries out a large variety of programs to ensure the rapid dissemination
of research information and its implementation in policy and
practice. Fact sheets on the health effects of drugs of abuse
and information on NIDA research and other activities can be
found on the NIDA home page at http://www.drugabuse.gov
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov. |
|
